相关临床试验
6
1 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
5
83.3%
尚未招募
1
16.7%
暂无批准数据
- Over 982,000 cases of infectious diseases were recorded across Thatta, Sujawal, and Badin districts from 2019 to 2022, with under-five diarrhoea and suspected malaria predominating. - Disease incidence rose with higher temperature, humidity, and precipitation, with malaria peaking 4–6 weeks after monsoon rainfall and diarrhoea showing dual seasonal peaks. - Malaria cases in Pakistan rose fivefold between 2021 and 2022, making it the second-highest malaria-burdened country in the WHO Eastern Mediterranean Region. - Researchers call for integrating real-time meteorological data into healthcare surveillance systems to anticipate outbreaks and allocate resources proactively in vulnerable coastal communities.
- A new clinical trial in Kenya is evaluating Roche's GDC-6036, a novel drug targeting the KRAS gene, in cancer patients. - The trial aims to determine if GDC-6036 can effectively block the mutation of the KRAS gene into the KRAS G12C variant, which is implicated in various cancers. - The study emphasizes the importance of conducting clinical trials in Africa to develop therapies that are better suited to the genetic specifications of African populations. - The trial seeks to provide new treatment options for cancer patients and contribute to the advancement of precision oncology in the region.
